written on 26.03.2014
Tags:
,

NICE issues final no for Sanofi's Zaltrap

TAGS: ,

NICE assessed Zaltrap in combination with irinotecan and fluorouracil-based therapy (FOLFIRI) for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy. The institute, which conducts health technology…

Latest Report